[1]Burn DJ, Troster AI.Neuropsychiatric complications of medical and surgical therapies for Parkinson’ s disease [J].J Geriatr Psychiatry Neurol,2004,17(3):172180.
[2] Cookson MR. The biochemistry of Parkinson’s disease [J]. Annu Rev Biochem, 2005,74:2952.
[3]杨明会,窦永起,刘毅,等. 抑颤汤治疗帕金森病临床对照观察[J].中国中西医结合急救杂志,2002,9(9):256258.
[4]窦永起,杨明会,刘毅,等.中西医结合治疗帕金森病疗效的对照观察[J].中国临床康复,2006,10(19):68.
[5]Ogden JA, Grow don JH, Cork in S. Deficits on visuospatial tests involving forward planning in highfunctioning Parkinsonism[J]. J Neuropsychiatry, 1990, 3(1): 125.
[6]Gibb UR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson′s disease[J]. JNeurol Neurosurg Psychiatry, 1988, 51(6): 745752.
[7]Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality[J]. J Neurol,1967, 17(6): 427.
[8]陈生弟,乐卫东,陈先文,等.帕金森病[M].北京:人民卫生出版社,2006:286.
[9]梅磊.ET脑功能研究新技术[M].北京:国防工业出版社,1995: 256267,288300.
[10]张丽,魏文石,朱国行,等.早期帕金森患者的执行功能与脑涨落图研究 [J]. 老年医学与保健,2006,12(4):225227.
[11]刘昌,李德明,梅磊.大脑慢电活动研究及其进展[J]. 心理学动态,1996,(4):1318.
[12]Brooks DJ, Frey KA, Marek KL, et al. Assessmentofneuromi aging techniques as biomarkers of the progression of Parkinson′s disease[J]. Exp Neuro,2003, 184(S): 6879.
[13]杨虹,张莉萍,魏桂荣,等.DA/Ach动态平衡在帕金森病发病中研究进展[J].中国老年学杂志,2009, 29(13):17081710.
[14]Zhou L, Lin Z, Lin L, et al. Functional constipation: implications for nursing interventions[J].Clin Nurs, 2010, 19: 18381843.
[15]Devanarayana NM,Rajindrajith S.Association between constipation and stressful life events in a cohort of Sri Lankan children and adolescents. J Trop Pediatr, 2010, 56: 144148.
[16]Crowell MD, Wessinger SB. 5HT and the braingut axis: opportunities for pharmacologic intervention[J]. Expert Opin Investig Drugs,2007,16:761765.
[17]王丽敏,刘中霖,陶恩祥,等.帕金森病患者血浆单胺类神经递质的变化水平[J].中国临床康复,2005,9(5):6061.
[18]刘道宽,蒋雨平,江澄川,等.锥体外系疾病[M].上海:上海科学技术出版社,2000:7374.
[19]杨明会,李军艳,刘毅,等.系统论引领帕金森病治疗思路[J].医学与哲学,2009,30(2):35.
[1]霍青 于亚萍.中药治疗帕金森病临床疗效的系统评价[J].环球中医药,2014,7(01):29.
HUO Qing,YU Ya ping..Systemically review of the clinical curative effect of Parkinsons disease treated with traditional Chinese medicine(TCM)[J].,2014,7(10):29.
[2]郭云霞,杨明会.中医药干预帕金森病实验研究进展[J].环球中医药,2013,6(10):773.
GUO Yun xia,YANG Ming hui..Animal experimental study progress of TCM intervention on Parkinsons disease[J].,2013,6(10):773.
[3]霍青,柳琳,李强,等.水木和宁方改善帕金森病患者生活质量的研究[J].环球中医药,2016,9(12):1553.[doi:10.3969/j.issn.1674-1749.2016.12.039]
[4]李婷 田金洲 秦斌 樊东升 刘建平 刘娜 费宇彤 李雨濛 靳昭晖 时晶.帕金森病100例中医证候特征分析[J].环球中医药,2017,10(09):1009.[doi:10.3969/j.issn.1674-1749.2017.09.022]
[5]徐睿鑫,李绍旦,刘毅,等.补肾活血颗粒对帕金森病模型大鼠黑质纹状体bcl-2、bax表达的影响[J].环球中医药,2015,8(04):415.[doi:10.3969/j.issn.1674-1749.2015.04.008]
XU Rui-xin,LI Shao-dan,LIU Yi,et al.The effects of Bushen huoxue Granule on the expressions of bcl-2 and bax in substantia nigra and striatum in rats models with Parkinson's disease[J].,2015,8(10):415.[doi:10.3969/j.issn.1674-1749.2015.04.008]